(November 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in The Fifth Annual Merrill Lynch Med Tech Fundamentals Conference, which is being held on Thursday, December 1st in New York City.

Paul LaViolette, Boston Scientific Chief Operating Officer, will participate in a panel discussion related to Interventional Cardiology beginning at approximately 10:30 a.m. ET.

A live webcast and archived replay of Mr. LaViolette